JY
KRTX

Jeff Yass’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Jeff Yass’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-221,300
Closed -$70M – 13732
2023
Q4 		$70M Buy
221,300
+63,400
+40% +$12.3M 0.01% 856
2023
Q3 		$26.7M Sell
157,900
-15,800
-9% -$2.97M 0.01% 1482
2023
Q2 		$37.7M Sell
173,700
-80,300
-32% -$17.2M 0.01% 1187
2023
Q1 		$46.1M Buy
254,000
+79,400
+45% +$15.2M 0.01% 1002
2022
Q4 		$34.3M Buy
174,600
+63,100
+57% +$13.5M 0.01% 1103
2022
Q3 		$25.1M Sell
111,500
-124,500
-53% -$25.2M 0.01% 1230
2022
Q2 		$29.9M Buy
236,000
+124,400
+111% +$14.3M 0.01% 1152
2022
Q1 		$14.2M Buy
111,600
+98,200
+733% +$11.1M ﹤0.01% 2101
2021
Q4 		$1.75M Sell
13,400
-28,000
-68% -$3.62M ﹤0.01% 5818
2021
Q3 		$5.06M Buy
41,400
+12,200
+42% +$1.41M ﹤0.01% 3937
2021
Q2 		$3.33M Buy
29,200
+11,700
+67% +$1.37M ﹤0.01% 4798
2021
Q1 		$2.1M Buy
17,500
+5,600
+47% +$634K ﹤0.01% 5807
2020
Q4 		$1.21M Sell
11,900
-7,400
-38% -$686K ﹤0.01% 6266
2020
Q3 		$1.49M Buy
19,300
+16,400
+566% +$1.4M ﹤0.01% 5192
2020
Q2 		$323K Sell
2,900
-300
-9% -$26.1K ﹤0.01% 8230
2020
Q1 		$230K Buy
+3,200
New +$274K ﹤0.01% 8453

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Jeff Yass's KRTX Position: Q1 2024 in Review

Jeff Yass sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 38,118 shares — an estimated $12.1M sold.

Jeff Yass first reported a position in KRTX in Q1 2020 and held it in 16 quarters. The position peaked at $22.9M in Q2 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Jeff Yass reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Jeff Yass sold 38,118 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $12.1M.
  • Jeff Yass first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • Jeff Yass's Karuna Therapeutics, Inc. Common Stock position peaked at $22.9M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.